Vera Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing treatments for immunological and inflammatory diseases that improve patients’ lives.
Location: United States, California, South San Francisco
Member count: 11-50
Total raised: $80M
Founded date: 2016
Investors 6
Date | Name | Website |
- | Octagon Ca... | octagoninv... |
04.08.2023 | Internatio... | ibtplc.com |
08.11.2020 | Sofinnova ... | sofinnova.... |
19.01.2021 | Abingworth... | abingworth... |
23.01.2021 | Longitude ... | longitudec... |
10.07.2021 | GV | gv.com |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
22.01.2021 | Series C | $80M | - | abingworth... |
Mentions in press and media 7
Date | Title | Description | Source |
08.12.2021 | Vera Bradley, Inc. announces an Equity Buyback for $50 milli... | Vera Bradley, Inc. (NasdaqGS:VRA) announces a share repurchase program. Under the program, the compa... | marketscre... |
20.04.2021 | Vera Therapeutics Appoints Industry Veteran Dr. Celia Lin as... | SOUTH SAN FRANCISCO, Calif., April 20, 2021 /PRNewswire/ -- Vera Therapeutics, Inc., a clinical-st... | prnewswire... |
25.01.2021 | Startup targets orphan kidney disease with former Merck drug | Photo: CaptureTheWorld, Getty Images Promoted This Patient Experience Checklist Is Your Key To Suc... | medcitynew... |
22.01.2021 | Vera Therapeutics Launches with $80M in Series C | SOUTH SAN FRANCISCO, CA, Vera Therapeutics announced its launch backed by $80 million Series C fin... | vcnewsdail... |
19.01.2021 | We are pleased to announce Vera Therapeutics has launched wi... | - | abingworth... |
19.01.2021 | Vera Therapeutics Launches with $80 Million Series C Financi... | SOUTH SAN FRANCISCO, Calif., Jan. 19, 2021 /PRNewswire/ -- Vera Therapeutics, Inc., a clinical-sta... | prnewswire... |
- | Startup targets orphan kidney disease with former Merck drug | Backed by $80 million in Series C funding, Vera Therapeutics is targeting a chronic kidney disease w... | medcitynew... |